SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d 12h ago SEC0000315066-26-002851
Passive stake amendment
Actionable Insight • Neutral

Fidelity's increased passive stake signals continued institutional confidence following the RASONQUE launch. Monitor for any future conversion to a 13D filing, which would indicate activist intent.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$177.65
T+0 close · Nov 5, 2026 · via day close
Latest settled
−0.73%
T+5 · $176.35
Vs SPY
−4.02%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $177.65entry
  2. T+1 · 11d ago +8.24%α +7.92% · $192.28
  3. T+5 · 5d ago −0.73%α −4.02% · $176.35
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 7.2% passive stake in Revolution Medicines as of September 30, 2026, up from a prior filing. The increase reflects Fidelity's continued accumulation following the company's strong Q3 earnings beat from its newly approved drug RASONQUE.

Key Financial Metrics

Stake
7.2%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC (Fidelity) reported beneficial ownership of 15,402,102.97 shares of Revolution Medicines common stock as of September 30, 2026.
  • The stake represents 7.2% of shares outstanding.
  • This is an amendment to a prior Schedule 13G filing, indicating an increase from the previously reported position.
  • The filing is passive (Rule 13d-1(b)), with no intent to influence control.
  • Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the outstanding shares.

Financial Impact

FMR LLC holds 15.4 million shares valued at approximately $3.0B based on the $41.6B market cap and 7.2% stake.

ownership_percentage

Risk Factors

  • Passive filing status means Fidelity has no current intent to influence management or strategy.
  • No information on the exact change in share count from the prior filing is provided in this document.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (31 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002851
Document: 0000315066-26-002851-index-headers.html0000315066-26-002851
Document: 0000315066-26-002851-index.html0000315066-26-002851
Document: 0000315066-26-002851.txt0000315066-26-002851

Track record

44 reports on RVMD

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
  5. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Viewing Entry $177.65 Now $166.87 −6.07% settles Feb 3
  6. Nov 4, 202612d ago 8-K Bullish 7/10 No price data
  7. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
  8. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
  9. Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
  10. Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
Showing 10 of 44

US Market Status

Market Closed · Opens in 7h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026